Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SHE:301246)
China flag China · Delayed Price · Currency is CNY
25.89
+0.69 (2.74%)
At close: Apr 29, 2026

SHE:301246 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
10,0009,9205,38510,392--
Market Cap Growth
83.66%84.22%-48.18%---
Enterprise Value
8,9299,2034,0688,758--
Last Close Price
25.2025.0013.5025.83--
PE Ratio
84.0383.33104.64119.22--
PS Ratio
5.165.123.045.06--
PB Ratio
2.242.231.242.38--
P/TBV Ratio
2.342.321.292.49--
P/OCF Ratio
---294.81--
EV/Sales Ratio
4.604.752.304.26--
EV/EBITDA Ratio
23.2024.2219.1039.79--
EV/EBIT Ratio
50.0551.58115.30136.98--
Debt / Equity Ratio
0.120.120.090.080.210.05
Debt / EBITDA Ratio
1.381.381.751.581.240.18
Net Debt / Equity Ratio
-0.24-0.24-0.38-0.42-0.02-0.02
Net Debt / EBITDA Ratio
-2.81-2.81-7.75-8.32-0.15-0.09
Net Debt / FCF Ratio
3.143.149.384.170.180.66
Asset Turnover
0.320.320.310.430.650.75
Inventory Turnover
5.345.346.886.674.402.89
Quick Ratio
2.062.062.353.200.931.01
Current Ratio
2.662.662.683.501.261.67
Return on Equity (ROE)
2.67%2.67%1.18%2.69%22.93%34.51%
Return on Assets (ROA)
1.86%1.86%0.38%0.84%5.18%10.62%
Return on Invested Capital (ROIC)
4.11%4.72%1.16%2.46%12.86%23.80%
Return on Capital Employed (ROCE)
3.60%3.60%0.80%1.40%10.20%19.60%
Earnings Yield
1.19%1.20%0.96%0.84%--
FCF Yield
-3.41%-3.44%-3.27%-4.23%--
Dividend Yield
0.12%-0.22%0.19%--
Payout Ratio
23.58%23.58%59.97%61.72%3.44%0.45%
Buyback Yield / Dilution
0.42%0.42%-2.71%-10.02%0.00%-0.13%
Total Shareholder Return
0.54%0.42%-2.49%-9.83%0.00%-0.13%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.